ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,901,000 | +37.7% | 1,433,304 | 0.0% | 99.96% | +0.1% |
| Q2 2018 | $6,464,000 | -2.0% | 1,433,304 | 0.0% | 99.88% | +0.1% |
| Q1 2018 | $6,593,000 | +43.3% | 1,433,304 | 0.0% | 99.80% | +1848.5% |
| Q4 2017 | $4,601,000 | +4.2% | 1,433,304 | 0.0% | 5.12% | +2.2% |
| Q3 2017 | $4,415,000 | -16.7% | 1,433,304 | 0.0% | 5.01% | -42.3% |
| Q2 2017 | $5,303,000 | -24.2% | 1,433,304 | 0.0% | 8.68% | -31.5% |
| Q1 2017 | $6,995,000 | -4.7% | 1,433,304 | 0.0% | 12.68% | -16.6% |
| Q4 2016 | $7,339,000 | -29.3% | 1,433,304 | 0.0% | 15.19% | +10.6% |
| Q3 2016 | $10,377,000 | +11.6% | 1,433,304 | 0.0% | 13.73% | +15.1% |
| Q2 2016 | $9,302,000 | -19.8% | 1,433,304 | 0.0% | 11.94% | -25.1% |
| Q1 2016 | $11,595,000 | +0.2% | 1,433,304 | 0.0% | 15.93% | +13.2% |
| Q4 2015 | $11,567,000 | – | 1,433,304 | – | 14.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |